In memoriam: Michael Sela
Michael Sela, an immunologist and synthetic chemist who helped develop drugs to treat multiple sclerosis and cancer died May 27, 2022, in Rehovot, Israel. He was 98.
A member of the American Society for Biochemistry and Molecular Biology since 1968, Sela was the sixth president of the Weizmann Institute of Science and founding director of its immunology department.
Sela was born Miechzslaw Salomoniwicz in Poland on Feb. 28, 1924. Rising antisemitism drove his family first to Romania, and then to Palestine, where Sela arrived at age 17. He earned a master’s degree in chemistry at the Hebrew University in 1946, then moved to Italy to help resettle Jewish refugees and served as a diplomat in Prague. In 1950, he went to the Weizmann Institute as a doctoral student of Efraim Katzir, later a president of Israel. He earned a Ph.D. in chemistry through Hebrew University.
Sela’s work on synthetic antigens helped illuminate how genes control the immune response. He was one of the first chemists to create multichain polymers of amino acids and polypeptide proteins. This basic science indirectly led to his co-inventing the drug Copaxone (glatiramer acetate) for multiple sclerosis and three cancer drugs cetuxibab, necitumumab and panitumumab.
In addition to serving as president of the Weizmann Institute from 1975 to 1985, Sela led the International Union of Immunological Societies, chaired the Council of the European Molecular Biology Organization and joined the Global Advisory Committee of the World Health Organization. He was a member of the Israel, U.S. National, Russian, French and Pontifical academies of sciences.
Among many honors, Sela received the 1980 Gairdner Foundation International Award, UNESCO's Albert Einstein Golden Medal in 1995 and the 1998 Wolf Prize in Medicine, shared with his first grad student, Ruth Arnon.
Sela enjoyed and supported the performing arts, from the Batsheva Dance Company to classical music, jazz, theater and opera. He was a gifted linguist, who mastered Polish, Romanian, Hebrew, German, Russian, French, English, Italian and Czech.
Sela’s first wife, Margalit Liebman, died in 1975. He is survived by his wife, Sara Kika; daughters, Irit, Orlee and Tamar, and their spouses; grandchildren; and great-grandchildren.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles
Cadichon honored for academic achievement
She won the State University of New York at Old Westbury’s Dr. Henry Teoh Award for Outstanding Collegiate Science and Technology Entry Program Graduating Senior, which recognizes exceptional achievement, leadership and promise in a student.
In memoriam: Ralph G. Yount
He was a professor emeritus of chemistry and biochemistry at Washington State University and an ASBMB member for 58 years.
From dust to discovery
From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women’s health.
Fliesler wins scientific and ethical awards
He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.
Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.
Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.